CurrentRheuma coverage · page 32 of 48

Rheumatology (Oxford)

Briefs 1,241–1,280 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

Rheumatology (Oxford)26 Dec 2023
Ultrasound-based detection of inflammatory changes for early diagnosis and risk model construction of psoriatic arthritis
Cross-sectional studySpondyloarthritis & PsA
Rheumatology (Oxford)25 Dec 2023
Efficacy and safety of belimumab in patients with lupus nephritis: a real-world retrospective observational study
Cohort studyLupus & APS
Rheumatology (Oxford)25 Dec 2023
Shelterin dysfunction promotes CD4+ T cell senescence in Behçet’s disease
Mechanistic studyVasculitis & PMR
Rheumatology (Oxford)23 Dec 2023
Steroid hormones in systemic sclerosis: associations with disease characteristics and modifications during scleroderma renal crisis
Cross-sectional studySystemic sclerosis
Rheumatology (Oxford)23 Dec 2023
Transcriptomic features of systemic lupus erythematosus patients in flare and changes during acute in-hospital treatment
Mechanistic studyLupus & APS
Rheumatology (Oxford)22 Dec 2023
Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis in children
Diagnostic or prognostic studyPediatric
Rheumatology (Oxford)22 Dec 2023
The incidence and prevalence of juvenile idiopathic arthritis differs between ethnic groups in England
Cohort studyPediatric
Rheumatology (Oxford)21 Dec 2023
Patient–physician discordance impairs outcomes in early rheumatoid arthritis through less consistent treat-to-target implementation
Secondary analysisRA
Rheumatology (Oxford)21 Dec 2023
Regional differences in clinical phenotype of axial spondyloarthritis: results from the International Map of Axial Spondyloarthritis (IMAS)
Cross-sectional studySpondyloarthritis & PsA
Rheumatology (Oxford)20 Dec 2023
Quantifying hospital-associated costs, and accompanying travel costs and productivity losses, before and after withdrawing TNF-α inhibitors in juvenile idiopathic arthritis
Cohort studyPediatric
Rheumatology (Oxford)18 Dec 2023
IL-10 and IFN-γ as markers for early recognition of pediatric systemic lupus erythematosus complicated with macrophage activation syndrome
Case-control studyPediatric
Rheumatology (Oxford)18 Dec 2023
Attribution of neuropsychiatric symptoms and prioritization of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE study
Research articleLupus & APS
Rheumatology (Oxford)14 Dec 2023
Clinical heterogeneity and prognostic factors of anti-synthetase syndrome: a multi-centred retrospective cohort study
Cohort studyMyositis
Rheumatology (Oxford)13 Dec 2023
A potential role for chlamydial infection in rheumatoid arthritis development
Case-control studyRA
Rheumatology (Oxford)13 Dec 2023
Fracture prediction in rheumatoid arthritis: validation of FRAX with bone mineral density for incident major osteoporotic fractures
Cohort studyOsteoporosis
Rheumatology (Oxford)13 Dec 2023
Organ damage is a major determinant of work productivity impairment in Behçet’s syndrome: a post hoc analysis of the BODI validation study
Secondary analysisVasculitis & PMR
Rheumatology (Oxford)12 Dec 2023
The cost-effectiveness of adding an ultrasound corticosteroid and local anaesthetic injection to advice and education for hip osteoarthritis
Research articleOsteoarthritis
Rheumatology (Oxford)12 Dec 2023
Cancer risks in patients with ankylosing spondylitis and the effects of biologic agents: a population-based study
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)11 Dec 2023
Landscape of immune cells in systematic lupus erythematosus patients with Epstein–Barr virus infection: assessed by single-cell sequencing
Mechanistic studyLupus & APS
Rheumatology (Oxford)9 Dec 2023
Non-trough serum drug levels of adalimumab and etanercept are associated with response in patients with psoriatic arthritis
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)9 Dec 2023
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study
Cohort studyAcross diseases
Rheumatology (Oxford)9 Dec 2023
Cost-of-illness changes before and after the diagnosis of systemic lupus erythematosus: a nationwide, population-based observational study in Korea
Cohort studyLupus & APS
Rheumatology (Oxford)9 Dec 2023
The efficacy of rituximab plus belimumab or telitacicept in refractory lupus nephritis
Cohort studyLupus & APS
Rheumatology (Oxford)7 Dec 2023
The emerging role of growth differentiation factor 15 as a potential disease biomarker in juvenile dermatomyositis
Research articleMyositis
Rheumatology (Oxford)6 Dec 2023
Gastrointestinal manifestations in systemic lupus erythematosus: data from an Indian multi-institutional inception (INSPIRE) cohort
Cohort studyLupus & APS
Rheumatology (Oxford)6 Dec 2023
Hip dysplasia as risk factor for clinically relevant and radiographic hip osteoarthritis: 10-year results from the CHECK cohort
Cohort studyOsteoarthritis
Rheumatology (Oxford)4 Dec 2023
Risk of atrial fibrillation in patients with systemic sclerosis: a nationwide population-based study
Cohort studySystemic sclerosis
Rheumatology (Oxford)4 Dec 2023
Lung ultrasound and high-resolution computed tomography quantitative variations during nintedanib treatment for systemic sclerosis-associated interstitial lung disease
Cohort studySystemic sclerosis
Rheumatology (Oxford)4 Dec 2023
Factors associated with treatment intensification in patients with axial spondyloarthritis and high disease activity in clinical practice
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)4 Dec 2023
Estimating overdiagnosis in giant cell arteritis diagnostic pathways using genetic data: genetic association study
Research articleVasculitis & PMR
Rheumatology (Oxford)4 Dec 2023
Impact of gender on baseline presentation and outcome in adult IgA vasculitis
Cohort studyVasculitis & PMR
Rheumatology (Oxford)4 Dec 2023
Impact of serological activity on flare following clinically inactive disease and remission in childhood-onset systemic lupus erythematosus
Cohort studyPediatric
Rheumatology (Oxford)4 Dec 2023
Rheumatoid arthritis, quantitative parenchymal lung features and mortality among smokers
Cross-sectional studyRA
Rheumatology (Oxford)4 Dec 2023
Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis
Cross-sectional studyRA
Rheumatology (Oxford)4 Dec 2023
Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk
Cross-sectional studyLupus & APS
Rheumatology (Oxford)1 Dec 2023
Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease
Cohort studyMyositis
Rheumatology (Oxford)27 Nov 2023
Real-world efficacy of belimumab in systemic lupus erythematosus: a prospective cohort from a single centre in China
Cohort studyLupus & APS
Rheumatology (Oxford)27 Nov 2023
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis
Cross-sectional studySpondyloarthritis & PsA
Rheumatology (Oxford)25 Nov 2023
Genetic testing of Behçet’s disease using next-generation sequencing to identify monogenic mimics and HLA-B*51
Diagnostic or prognostic studyVasculitis & PMR
Rheumatology (Oxford)24 Nov 2023
Long-term outcomes of lupus nephritis with low-level proteinuria: a multicentre, retrospective study
Cohort studyLupus & APS

All 1,905 Briefs in ExploreShowing Briefs 1,241–1,280 of 1,905, newest first